CD1-MR1 2015* , ,
Presentations this author is a contributor to:
Alternative developmental pathway of a Va14+ NKT cell subset bypassing CD4+CD8+ double positive stage (#2)
8:00 AM
Masaru Taniguchi
Session 1 - Development and Subsets I
A validation of the requirement for Vα14 NKT cells for tumor rejection using newly generated Traj18-deficient mice with undisturbed T cell receptor repertoire (#49)
6:35 PM
Nyambayar Dashtsoodol
Rapid Fire Talks II